DWA
Dorsey Wright & Associates’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $365K | Hold |
468
| – | – | 0.09% | 113 |
|
2025
Q1 | $387K | Sell |
468
-16,101
| -97% | -$13.3M | 0.1% | 108 |
|
2024
Q4 | $12.8M | Sell |
16,569
-2,164
| -12% | -$1.67M | 3.05% | 2 |
|
2024
Q3 | $16.6M | Buy |
18,733
+271
| +1% | +$240K | 3.93% | 1 |
|
2024
Q2 | $16.7M | Buy |
18,462
+2
| +0% | +$1.81K | 4.34% | 1 |
|
2024
Q1 | $14.4M | Buy |
18,460
+2,672
| +17% | +$2.08M | 3.75% | 1 |
|
2023
Q4 | $9.2M | Sell |
15,788
-1,056
| -6% | -$616K | 2.8% | 1 |
|
2023
Q3 | $9.05M | Buy |
16,844
+431
| +3% | +$232K | 2.81% | 1 |
|
2023
Q2 | $7.7M | Sell |
16,413
-417
| -2% | -$196K | 2.32% | 2 |
|
2023
Q1 | $5.78M | Sell |
16,830
-5,528
| -25% | -$1.9M | 1.75% | 6 |
|
2022
Q4 | $8.18M | Buy |
+22,358
| New | +$8.18M | 2.39% | 2 |
|
2022
Q2 | $2.5M | Buy |
7,714
+6,146
| +392% | +$1.99M | 0.73% | 71 |
|
2022
Q1 | $449K | Sell |
1,568
-7,418
| -83% | -$2.12M | 0.1% | 106 |
|
2021
Q4 | $2.48M | Sell |
8,986
-313
| -3% | -$86.5K | 0.51% | 92 |
|
2021
Q3 | $2.15M | Buy |
+9,299
| New | +$2.15M | 0.47% | 99 |
|
2019
Q3 | – | Sell |
-2,651
| Closed | -$294K | – | 315 |
|
2019
Q2 | $294K | Sell |
2,651
-15,243
| -85% | -$1.69M | 0.07% | 122 |
|
2019
Q1 | $2.32M | Buy |
17,894
+2,133
| +14% | +$277K | 0.56% | 76 |
|
2018
Q4 | $1.82M | Buy |
+15,761
| New | +$1.82M | 0.55% | 77 |
|
2015
Q4 | – | Sell |
-5,158
| Closed | -$432K | – | 117 |
|
2015
Q3 | $432K | Buy |
+5,158
| New | +$432K | 0.23% | 69 |
|